BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang D, Gao M, Jin Q, Ni Y, Zhang J. Updated developments on molecular imaging and therapeutic strategies directed against necrosis. Acta Pharm Sin B 2019;9:455-68. [PMID: 31193829 DOI: 10.1016/j.apsb.2019.02.002] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Liapis V, Tieu W, Wittwer NL, Gargett T, Evdokiou A, Takhar P, Rudd SE, Donnelly PS, Brown MP, Staudacher AH. Positron Emission Tomographic Imaging of Tumor Cell Death Using Zirconium-89-Labeled APOMAB® Following Cisplatin Chemotherapy in Lung and Ovarian Cancer Xenograft Models. Mol Imaging Biol 2021. [PMID: 34231102 DOI: 10.1007/s11307-021-01620-1] [Reference Citation Analysis]
2 Yan YY, Guo QR, Wang FH, Adhikari R, Zhu ZY, Zhang HY, Zhou WM, Yu H, Li JQ, Zhang JY. Cell-Free DNA: Hope and Potential Application in Cancer. Front Cell Dev Biol 2021;9:639233. [PMID: 33693004 DOI: 10.3389/fcell.2021.639233] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
3 Zhang Q, Dai X, Zhang H, Zeng Y, Luo K, Li W. Recent advances in development of nanomedicines for multiple sclerosis diagnosis. Biomed Mater 2021;16:024101. [PMID: 33472182 DOI: 10.1088/1748-605X/abddf4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Zhang D, Jin Q, Ni Y, Zhang J. Discovery of necrosis avidity of rhein and its applications in necrosis imaging. J Drug Target 2020;28:904-12. [PMID: 32314601 DOI: 10.1080/1061186X.2020.1759079] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Zhang D, Jiang C, Feng Y, Ni Y, Zhang J. Molecular imaging of myocardial necrosis: an updated mini-review. J Drug Target 2020;28:565-73. [PMID: 32037899 DOI: 10.1080/1061186X.2020.1725769] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Alu A, Han X, Ma X, Wu M, Wei Y, Wei X. The role of lysosome in regulated necrosis. Acta Pharm Sin B 2020;10:1880-903. [PMID: 33163342 DOI: 10.1016/j.apsb.2020.07.003] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 12.0] [Reference Citation Analysis]
7 Liapis V, Tieu W, Rudd SE, Donnelly PS, Wittwer NL, Brown MP, Staudacher AH. Improved non-invasive positron emission tomographic imaging of chemotherapy-induced tumor cell death using Zirconium-89-labeled APOMAB®. EJNMMI Radiopharm Chem 2020;5:27. [PMID: 33205364 DOI: 10.1186/s41181-020-00109-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
8 Zhang L, Liu L, Zhang D, Jin Q, Gao M, Wu T, Feng Y, Ni Y, Yin Z, Zhang J. Synthesis and Evaluation of Diindole-Based MRI Contrast Agent for In Vivo Visualization of Necrosis. Mol Imaging Biol 2020;22:593-601. [PMID: 31332630 DOI: 10.1007/s11307-019-01399-2] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
9 Jiang C, Zhang J, Hu S, Gao M, Zhang D, Yao N, Jin Q. Target identification and occupancy measurement of necrosis avid agent rhein using bioorthogonal chemistry-enabling probes. RSC Adv 2022;12:16491-5. [PMID: 35754899 DOI: 10.1039/d2ra02844a] [Reference Citation Analysis]
10 Zeng Y, Li H, Li Z, Luo Q, Zhu H, Gu Z, Zhang H, Gong Q, Luo K. Engineered gadolinium-based nanomaterials as cancer imaging agents. Applied Materials Today 2020;20:100686. [DOI: 10.1016/j.apmt.2020.100686] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
11 Zhang D, Jin Q, Jiang C, Gao M, Ni Y, Zhang J. Imaging Cell Death: Focus on Early Evaluation of Tumor Response to Therapy. Bioconjug Chem 2020;31:1025-51. [PMID: 32150392 DOI: 10.1021/acs.bioconjchem.0c00119] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
12 Han X, Taratula O, Taratula O, Xu K, St Lorenz A, Moses A, Jahangiri Y, Yu G, Farsad K. Biodegradable Hypericin-Containing Nanoparticles for Necrosis Targeting and Fluorescence Imaging. Mol Pharm 2020;17:1538-45. [PMID: 32212709 DOI: 10.1021/acs.molpharmaceut.9b01238] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
13 Li H, Zeng Y, Zhang H, Gu Z, Gong Q, Luo K. Functional gadolinium-based nanoscale systems for cancer theranostics. J Control Release 2021;329:482-512. [PMID: 32898594 DOI: 10.1016/j.jconrel.2020.08.064] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
14 Zhang D, Jin Q, Gao M, Jiang C, Ni Y, Zhang J. Untiring Pursuit for Glucarate-Based Molecular Imaging Probes. Mol Imaging Biol 2021;23:310-22. [PMID: 33206335 DOI: 10.1007/s11307-020-01564-y] [Reference Citation Analysis]